Science Daily: Pharmacology News
MAY 14, 2024
The vast majority of people have an ongoing conversation with themselves, an inner voice, that plays an important role in their daily lives. But between 5-10 per cent of the population do not have the same experience of an inner voice, and they find it more difficult to perform certain verbal memory tasks, new research shows.
Perficient: Drug Development
MAY 14, 2024
In the ever-evolving landscape of healthcare, trust reigns supreme. As consumers increasingly rely on data to inform their decisions, the healthcare industry faces a pressing need to not only meet but exceed expectations. With disruptive forces emerging from various corners, healthcare organizations find themselves in a race to create personalized experiences that foster lasting engagement and trust.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
MAY 14, 2024
Researchers have found that 2023 was the hottest summer in the Northern Hemisphere in the past two thousand years, almost four degrees warmer than the coldest summer during the same period.
Drugs.com
MAY 14, 2024
TUESDAY, May 14, 2024 -- Semaglutide -- the active ingredient in the blockbuster weight-loss drugs Ozempic and Wegovy -- can produce long-term weight and heart health benefits, a pair of new studies show.Researchers found that overweight and obese.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Science Daily: Pharmacology News
MAY 14, 2024
Cinematography techniques can significantly increase user engagement with virtual environments and, in particular, the aesthetic appeal of what users see in virtual reality.
Perficient: Drug Development
MAY 14, 2024
We’re excited to announce our Data Cloud Expert specialization! This is the highest level of Salesforce-validated expertise for Data Cloud. This achievement isn’t just a milestone, it’s a testament to our commitment to revolutionizing how businesses leverage their data to drive business outcomes, unlock trapped data, and enhance customer experiences.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drug Channels
MAY 14, 2024
Contrary to what you may have heard, the Inflation Reduction Act’s (IRA) inflation rebates for Medicare Part B drugs do not always save money for seniors. As we document below, a growing share of Part B drugs have inflation-adjusted coinsurance rates that have been increasing , not declining. In many cases, the coinsurance rate declines only briefly before rebounding back to the standard 20% rate.
Drugs.com
MAY 14, 2024
TUESDAY, May 14, 2024 -- High temperatures across the Northern Hemisphere last summer were scorching and frequent enough to make it the hottest summer in two millennia, new research shows.Weather records based on scientific instruments only goes.
Science Daily: Pharmacology News
MAY 14, 2024
Astronomers discovered three of the oldest stars in the universe, and they live in our own galactic neighborhood. The stars are in the Milky Way's 'halo' -- the cloud of stars that envelopes the entire main galactic disk -- and they appear to have formed between 12 and 13 billion years ago, when the very first galaxies were taking shape.
Drugs.com
MAY 14, 2024
TUESDAY, May 14, 2024 -- Night shift work can increase a person’s risk of chronic disease, and a new study reveals one possible explanation for this.It appears that just a few days on a night shift schedule throws off body rhythms tied to.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Science Daily: Pharmacology News
MAY 14, 2024
Survey reveals nearly three-quarters of U.S. adults support using emerging technology to screen embryos during IVF for risk of developing certain health conditions or traits that arise from more than one gene. Only about one-third of respondents approved of using the technology to predict traits unrelated to disease. Nearly all expressed concerns about potential negative outcomes for individuals or society.
Drugs.com
MAY 14, 2024
TUESDAY, May 14, 2024 -- While some states have moved to severely curb women's access to abortion, including abortion pills, over 8,000 women living in those states are getting the pills by mail each month from states without such.
Conversations in Drug Development Trends
MAY 14, 2024
By: Amy Raymond, Derek Ansel, Nathan Chadwick, & Juliane Mills When choosing a CRO for a rare disease study, what truly sets them apart is their methodology: the CRO’s mindset, their approach to each unique study, and their agility in navigating the inherent complexities of rare disease research. The team’s ability to apply insights and proven strategies from their experience in rare disease research brings concepts to reality, getting medications to patients faster.
Drugs.com
MAY 14, 2024
TUESDAY, May 14, 2024 -- Vaping rates among U.S. kids in grades 9 through 12 fell to 5% in 2021, the latest year for which data is available. That's down from a peak of 7.2% of teens who vaped in 2019, a new report finds.However, the 5% vaping rate.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Science Daily: Pharmacology News
MAY 14, 2024
Astronomers have just discovered WASP-193b, an extraordinarily low-density giant planet orbiting a distant Sun-like star.
Drugs.com
MAY 14, 2024
TUESDAY, May 14, 2024 -- San Francisco is on the verge of passing a ban on "forever chemicals" in the protective clothing firefighters wear while battling blazes.City lawmakers are expected to pass an ordinance on Tuesday that will prohibit.
BioPharma Drive: Drug Pricing
MAY 14, 2024
The biotechs aim to marry FogPharma’s polypeptide science with Artbio’s lead-based radiopharmaceutical technology in one of the industry’s hottest fields.
Drugs.com
MAY 14, 2024
TUESDAY, May 14, 2024 -- Melanoma, while rare among Black Americans, is often detected later with devastating consequences, a new study finds.Black people are frequently diagnosed with melanoma at later stages, increasing their risk of death.
BioPharma Drive: Drug Pricing
MAY 14, 2024
The reduction of 1,500 roles in the first quarter is part of CEO Bill Anderson’s plan to shrink Bayer’s bureaucracy and “radically realign” its culture.
Drugs.com
MAY 14, 2024
TUESDAY, May 14, 2024 (HeathDay News) -- Following decades of declines, drowning deaths are once again climbing in the United States, new government data shows. More than 4,500 people died from drowning each year in 2020 through 2022, 500 more per.
BioPharma Drive: Drug Pricing
MAY 14, 2024
The firm, one of the sector’s more active crossover investors, closed the fund during a surge in the financings that bridge biotechs to the public markets.
Science Daily: Pharmacology News
MAY 14, 2024
A young whale's journey across the Mediterranean highlights the many threats facing ocean animals, researchers say.
thought leadership
MAY 14, 2024
Compiling and submitting a New Drug Application ( NDA) submission is a complicated and intensive activity. Once you have submitted your application to FDA, you may be curious about what can you expect to hear and when. Below are some of the common questions we receive from Sponsors about what to expect during the NDA review process.
Cytel
MAY 14, 2024
Written by Angela Vinken and Patti Arsenault Key Opinion Leaders (KOLs) — i.e., trusted, well-respected experts — are crucial in clinical research, especially in rare diseases. They have the expertise, network, and experience to add great scientific value to clinical research and can influence and shape the trajectory of clinical research within their professional communities.
Perficient: Drug Development
MAY 14, 2024
The Summer ‘24 release preview is out and will be generally available by mid-June! The latest release from Salesforce brings critical feature improvements for our friends in the Healthcare & Life Sciences (HLS) industry. Of course, the hot topic in Tech over the last year has been Artificial Intelligence (AI). As Salesforce continues to beef up its AI offerings, the HLS industry using Health Cloud will reap the benefits of new and improved generative AI features that make a substantial diff
Drug Target Review
MAY 14, 2024
How do hydrophobicity, electrostatic charge, and secondary confirmation of helical polypeptides influence the stimulation of innate immune pathways in antigen-presenting cells (APCs)? These physical properties directly affect physical disruption of membrane integrity, which can activate endoplasmic reticulum (ER) stress to initiate pro-inflammatory signalling specifically in APCs.
Drug Patent Watch
MAY 14, 2024
Annual Drug Patent Expirations for GAVRETO Gavreto is a drug marketed by Blueprint Medicines and is included in one NDA. It is available from one supplier.
NIOSH Science Blog: Drugs
MAY 14, 2024
The National Institute for Occupational Safety and Health (NIOSH) Future of Work Initiative hosted a webinar to address the role of work arrangements in the future of work. Among the changes anticipated in the Future of Work is an increasing prevalence of nonstandard work arrangements, such as contingent, platform-based, seasonal, on-call, or other “nonstandard” work.
Drug Patent Watch
MAY 14, 2024
Annual Drug Patent Expirations for RECARBRIO Recarbrio is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier.
Fierce BioTech
MAY 14, 2024
Unlocking the Mystery: Data & Innovation in Women's Health swheeler Tue, 05/14/2024 - 16:10 Tue, 06/18/2024 - 11:00 Resource Type Webinar Vanessa Guzman, MSHA Sasha Ottey, MHA, MT (ASCP) Stacey Wasserman Cathy Zaremba Promotion Start Mon, 05/20/2024 - 12:15 Promotion End Wed, 11/20/2024 - 12:15 Duration 60 minutes Women's health deserves better!
Drug Patent Watch
MAY 14, 2024
Annual Drug Patent Expirations for PLUVICTO Pluvicto is a drug marketed by Novartis and is included in one NDA. It is available from one supplier.
Perficient: Drug Development
MAY 14, 2024
The previous blog post explored the initial steps of setting up Azure DevOps, creating projects, and navigating the Overview section. Now, let’s delve deeper into the other core sections of the Azure DevOps interface, Boards, and Repos, each playing a crucial role in your development lifecycle. Read the first part of the blog here: A Beginner’s Guide to Azure DevOps Navigating the Azure DevOps Interface The Azure DevOps interface is divided into sections mainly – Overview, Repo
Fierce BioTech
MAY 14, 2024
Your Guide to the Ultimate Pharmaceutical Product Improvement Tool This white paper will review how automating the annual product quality review (APQR) process can help pharmaceutical companies simplify and optimize their product quality review process, to make informed product quality decisions quicker and on a more routine and proactive basis. Download now!
Perficient: Drug Development
MAY 14, 2024
The most recent iteration of the Appium mobile automation framework is Appium 2. This edition includes numerous enhancements, new features, and improved performance. This tutorial will guide you through upgrading from Appium 1.x to Appium 2.x, stressing the advantages and providing code samples to illustrate them. Unlike Appium 1, Appium 2 does not have built-in support for iOS and Android.
Expert insights. Personalized for you.
128 
Let's personalize your content